Qualifications: Professor of Biopharmaceutics, Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University
About:Dr. Kaddoumi received her B.Sc. in Biochemistry from Kuwait University in 1985 and her M.S. in Pharmaceutical Sciences from Nagasaki University in 2001. Kaddoumi went on to complete her Ph.D. in Pharmaceutical Sciences from Nagasaki University in 2004.
Upon graduation, Kaddoumi took a positions as a postdoctoral research associate at the University of Michigan College of Pharmacy (2004-05) and the University of Washington School of Pharmacy (2005-06). In 2007, she joined the faculty at the University of Louisiana at Monroe School of Pharmacy (2007-17) in the Department of Basic Pharmaceutical Sciences.
Kaddoumi is an active member of the American Association of Pharmaceutical Scientists (AAPS), Society of Neuroscience (SfN), and the Oleocanthal International Society (OIS).
Research/Areas of Interest: Amal’s laboratory has extensive experience in drug development, preclinical research and bioanalysis in the fields of biopharmaceutics, neuropharmacology and brain research. The goal of Amal’s research is to enhance our knowledge and understanding of the contribution of vascular factors to neurological diseases, with a focus on Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA), in order to minimize the risk and to develop treatments that specifically target brain vasculature function.